Detalhe da pesquisa
1.
Recombinant ADAMTS13 in Congenital Thrombotic Thrombocytopenic Purpura.
N Engl J Med
; 390(17): 1584-1596, 2024 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38692292
2.
Autoantibodies Targeting Nephrin in Podocytopathies.
N Engl J Med
; 2024 May 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38804512
3.
IgA nephropathy in children with minimal proteinuria: to biopsy or not to biopsy?
Pediatr Nephrol
; 39(3): 781-787, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37698655
4.
Anti-CFH-associated hemolytic uremic syndrome: do we still need plasma exchange?
Pediatr Nephrol
; 2024 Apr 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38632123
5.
Successful global anti-B-cell strategy with daratumumab in a patient with post-transplant nephrotic syndrome recurrence unresponsive to immunoadsorption and obinutuzumab.
Pediatr Transplant
; 27(5): e14544, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37226549
6.
Renal vein thrombosis in neonates: a case series of diagnosis, treatment and childhood kidney function follow-up.
Pediatr Nephrol
; 38(9): 3055-3063, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36988695
7.
Incidence of idiopathic nephrotic syndrome during the Covid-19 pandemic in the Paris area (France) and in the Netherlands.
Pediatr Nephrol
; 38(11): 3681-3692, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37191940
8.
Pediatric ANCA vasculitis: clinical presentation, treatment, and outcomes in a French retrospective study.
Pediatr Nephrol
; 38(8): 2649-2658, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36622443
9.
Long-Term Efficacy and Safety of Repeated Rituximab to Maintain Remission in Idiopathic Childhood Nephrotic Syndrome: An International Study.
J Am Soc Nephrol
; 33(6): 1193-1207, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35354600
10.
Anti-rituximab antibodies in pediatric steroid-dependent nephrotic syndrome.
Pediatr Nephrol
; 37(2): 357-365, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34132894
11.
Specific immune biomarker monitoring in two children with severe IgA nephropathy and successful therapy with immunoadsorption in a rapidly progressive case.
Pediatr Nephrol
; 37(7): 1597-1603, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34997322
12.
A global antiB cell strategy combining obinutuzumab and daratumumab in severe pediatric nephrotic syndrome.
Pediatr Nephrol
; 36(5): 1175-1182, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33118048
13.
Both the rituximab dose and maintenance immunosuppression in steroid-dependent/frequently-relapsing nephrotic syndrome have important effects on outcomes.
Kidney Int
; 97(2): 393-401, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31874801
14.
Common risk variants in NPHS1 and TNFSF15 are associated with childhood steroid-sensitive nephrotic syndrome.
Kidney Int
; 98(5): 1308-1322, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32554042
15.
Treatment and long-term outcome in primary nephrogenic diabetes insipidus.
Nephrol Dial Transplant
; 2020 Dec 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-33367818
16.
Reply to Angeletti et al-Efficacy of combined rituximab and daratumumab treatment in posttransplant recurrent focal segmental glomerulosclerosis.
Am J Transplant
; 2024 Feb 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38387621
17.
APOL1 risk genotype in European steroid-resistant nephrotic syndrome and/or focal segmental glomerulosclerosis patients of different African ancestries.
Nephrol Dial Transplant
; 34(11): 1885-1893, 2019 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29992269
18.
Treating the idiopathic nephrotic syndrome: are steroids the answer?
Pediatr Nephrol
; 34(5): 777-785, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29869116
19.
Effect of different rituximab regimens on B cell depletion and time to relapse in children with steroid-dependent nephrotic syndrome.
Pediatr Nephrol
; 34(2): 253-259, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30109447
20.
Effect of nonsteroidal anti-inflammatory drugs in children with Bartter syndrome.
Pediatr Nephrol
; 34(4): 679-684, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30426218